Skip to content

Faculty profile

Bruno Larrivee

Back to faculty
ResearcherUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses and email address may be missing. Find their university profile.

Latest papers

  • Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.

    PloS one · 2021

  • The H2.0-like homeobox transcription factor modulates yolk sac vascular remodeling in mouse embryos.

    Arteriosclerosis, thrombosis, and vascular biology · 2014

All 2 publications

Latest funding

  • Role of COCO/Dand5 in visual function and assessment of its therapeutic potential for ocular pathologies.

    CIHR · 2022 · Nominated PI

    $699,975
  • IMAGE-GUIDED INJECTION WITH A HIGH-RESOLUTION ULTRASOUND SYSTEM ADAPTED FOR RODENT USE

    NSERC · 2022 · Co-investigator

    $146,541
  • Novel regulatory mechanisms of the mammalian nuclear proteasome through liquid-liquid phase separation

    CIHR · 2021 · Co-investigator

    $952,426
All 8 grants and awards
Something wrong or missing on this profile? Suggest a correction